Malignant Neuroendocrine Carcinoma clinical trials at UCSF

1 in progress, 0 open to eligible people

Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas
Sorry, in progress, not accepting new patients
This is a pilot study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinoma
San Francisco, California and other locations

Last updated: October 8, 2020